Latest Artificial pancreas Stories
An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of curing a disease that affects 3 million Americans."With just one injection of this gene therapy, the mice remain diabetes-free long term and have a return of normal insulin levels in the body," said Vijay Yechoor, MD, the principal investigator and an assistant...
WEST CHESTER, Pa., May 11, 2011 /PRNewswire/ -- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for people living with diabetes. The increased collaboration also will include more closely aligning their commercial organizations to actively co-promote their product offerings, such as the...
DANBURY, Conn., May 10, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin. The formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed mealtime insulin analogs. This study is designed as a double blinded, three-period cross over trial in which insulin pumps will be used to deliver...
WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System,(1,2) the first blood glucose monitoring device from Abbott that includes a mealtime (bolus) insulin calculator for calculating suggested insulin doses. The new FreeStyle InsuLinx System also offers several additional user-friendly features, including a touch screen interface, automated...
Decreasing blood levels of a protein that helps control inflammation may be a red flag that could help children avoid type 1 diabetes, researchers say.Georgia Health Sciences University researchers are looking at blood levels of interleukin-1 receptor antagonist, or IL-1ra, in children being closely followed because their genes put them at risk for type 1 diabetes. They also are looking at diabetic mice missing IL-1ra to see how the protein deficiency affects immune function and destruction...
Research: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomized controlled studiesTwo small randomised trials published on bmj.com today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of nocturnal hypoglycaemia (a sudden drop in blood glucose levels during the night) in adults with type 1 diabetes.The number of people with type 1...
Johns Hopkins researchers believe they have uncovered the molecular switch for the secretion of insulin "” the hormone that regulates blood sugar "” providing for the first time an explanation of this process. In a report published online March 1 in Cell Metabolism, the researchers say the work solves a longtime mystery and may lead to better treatments for type 2 diabetes, the most common form of the disease."Before our discovery, the mechanism behind how exactly the...
(Ivanhoe Newswire) -- About 1 million people are affected by type 1 diabetes in the United States. According to a new study, type 1 diabetes could be converted to an asymptomatic, non-insulin dependent disorder by eliminating the actions of a specific hormone.Type 1 diabetes is typically first diagnosed in children and teenagers. It is a disease where the body doesn't produce insulin -- a hormone that is needed to convert sugars, starches, and other food into energy.Glucagon is a hormone...
Parents and Clinicians to Learn About the Challenges and Opportunities of Raising a Child With Type 1 Diabetes at Free Juvenile Diabetes Research Foundation Summit Washington, DC (PRWEB) January 24, 2011 On Saturday, January 29th, hundreds of parents and clinicians from up and down the East Cost will have the opportunity to hear first-hand from some of the country's most prominent researchers about the latest developments in the prevention, management and cure of type 1 diabetes. The...
ALAMEDA, Calif., Dec. 22, 2010 /PRNewswire/ -- Abbott Diabetes Care today announced that it has initiated a recall of 359 lots (approximately 359 million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium(TM), Optium(TM), OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico. The test strips are used with Abbott's Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium and OptiumEZ blood glucose monitoring systems....
